Global Intensity Modulated Radiotherapy Market, By Radiation Type (Proton Radiation, Electron Radiation, Photon Radiation, Carbon-Lon Radiation), Application (Prostate Cancer, Lung Cancer, Breast Cancer, Brain Cancer, Gynaecological Cancers, Gastrointestinal Cancers, Other Cancers), End User (Hospitals, Independent Radiotherapy Centers, Other) – Industry Trends and Forecast to 2031.
Intensity Modulated Radiotherapy Market Analysis and Size
The market for intensity modulated radiotherapy is being driven by a number of factors, including the rising incidence of cancer and the advancements in radiotherapy technology, as well as an increase in the global elderly population. Furthermore, increased awareness about the benefits of IMRT among patients, healthcare professionals, and referring physicians has led to greater acceptance and adoption of this treatment modality. Collaboration between technology companies, healthcare institutions, and research organizations has led to the development of more innovative IMRT solutions, which are further driving market growth.
Data Bridge Market Research analyses that the global intensity-modulated radiotherapy Market, which was USD 2,374.20 million in 2023, is likely to reach USD 3,628.49 million by 2031 and is expected to undergo a CAGR of 5.4% during the forecast period. “Hospitals” dominates the end user segment of the market due to the convenience of consolidated medical services under one roof, streamlining patient care, and making IMRT an attractive treatment option there. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2014-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Radiation Type (Proton Radiation, Electron Radiation, Photon Radiation, Carbon-Lon Radiation), Application (Prostate Cancer, Lung Cancer, Breast Cancer, Brain Cancer, Gynaecological Cancers, Gastrointestinal Cancers, Other Cancers), End User (Hospitals, Independent Radiotherapy Centers, Other)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East & Africa
|
|
Market Players Covered
|
Mettler-Toledo (U.S.), Varian Medical Systems (U.S.), Elekta AB (Sweden), Accuray (U.S.), Siemens Healthineers (Germany), IBA Dosimetry (Belgium), Sun Nuclear Corporation (U.S.), ViewRay (U.S.), RaySearch Laboratories (Sweden), Mevion Medical Systems (U.S.), Hitachi Healthcare (Japan), Prowess Inc. (a subsidiary of Altair) (U.S.), Brainlab (Germany), Koninklijke Philips N.V.(Netherlands)
|
|
Market Opportunities
|
|
Market Definition
Intensity modulated radiotherapy (IMRT) is an advanced radiotherapy technique used in the treatment of various forms of cancer. IMRT is designed to deliver highly focused and precise doses of radiation to cancer cells while minimizing exposure to healthy surrounding tissues.
Global Intensity Modulated Radiotherapy Market Dynamics
Drivers
- Increasing Cancer Incidence
The rising incidence of cancer globally is a significant driver for the IMRT market. As the number of cancer cases continues to grow, the demand for effective and targeted radiation therapy methods like IMRT is also increasing. Thus, the market for intensity-modulated radiotherapy market is being driven by a number of factors, including the adoption of IMRT, which is growing in emerging markets due to increased healthcare spending and the expansion of healthcare infrastructure.
- Rising Geriatric Population
The rising cancer incidence and population ageing are two of the most important factors driving market growth. Globocan predicts that the number of new cancer cases will rise by 47% from 2020 to 28.4 million over the next two decades. Furthermore, the elderly are more vulnerable to cancer, and life expectancy in developing countries has surpassed 80 years. These are the certain factors which help the market to grow.
- Favourable Reimbursement Policies
In many developed countries, there are favourable reimbursement policies for radiotherapy treatments, including IMRT. This financial support encourages patients to opt for advanced and effective treatments like IMRT.
Moreover, increased awareness about the benefits of IMRT among patients, healthcare professionals, and referring physicians has led to greater acceptance and adoption of this treatment modality. This further accelerate the market growth.
Opportunities
- Increasing advancements in radiation therapy technologies to improve treatment
Ongoing advancements in radiotherapy technology, including improvements in imaging, treatment planning software, and delivery systems, have enhanced the precision and effectiveness of IMRT. These advancements are attracting both patients and healthcare providers. Image-guided radiotherapy (IGRT) involves the use of advanced imaging techniques, such as cone-beam CT scans and MRI, to precisely locate and track tumors in real time during treatment. This allows for adjustments in radiation delivery based on the tumor's position, minimizing damage to surrounding healthy tissues. This precise targeting minimizes radiation exposure to healthy tissues, making it especially useful in complex tumor shapes and locations, which can, in turn, will create lucrative market growth opportunities.
Moreover, collaboration between technology companies, healthcare institutions, and research organizations has led to the development of more innovative IMRT solutions, which will also work in the favour of the market.
Restraint/Challenge
- High Installation Cost of Intensity Modulated Radiotherapy Equipment
The acquisition and installation of IMRT equipment can be expensive. This cost can pose a significant barrier to healthcare facilities, particularly in resource-constrained regions, limiting the availability of IMRT services which is expected to obstruct market growth. Moreover, lack of highly skilled radiation oncologists, medical physicists, and radiation therapists that can be simply is projected to challenge the intensity modulated radiotherapy market in the forecast period of 2024-2031.
This intensity modulated radiotherapy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Intensity Modulated Radiotherapy Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In October 2020, Serialized Product Intelligence is a new cloud service developed by TraceLink that uses serialisation data to give actionable intelligence and operational excellence
Global Intensity Modulated Radiotherapy Market Scope
The intensity modulated radiotherapy market is segmented on the basis of radiation type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Radiation Type
- Proton Radiation
- Electron Radiation
- Photon Radiation
- Carbon-Ion Radiation
Application
- Prostate Cancer
- Lung Cancer
- Breast Cancer
- Brain Cancer
- Gynaecological Cancers
- Gastrointestinal Cancers
- Other Cancers
End User
- Hospitals
- Independent Radiotherapy Centers
- Other
Global Intensity Modulated Radiotherapy Market Regional Analysis/Insights
The Intensity Modulated Radiotherapy Market is analyzed, and market size insights and trends are provided by country, radiation type, application, and end-user, as referenced above.
The countries covered in the Intensity Modulated Radiotherapy Market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.
North America is expected to dominate the market due to rise in global geriatric population and government expenditures on healthcare in the region.
Asia-Pacific is expected to witness significant growth due to the growing aging demographic in Asia-Pacific countries underscores the need for effective cancer treatment with minimal adverse effects, aligning with IMRT's precision-driven attributes.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The intensity modulated radiotherapy market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for intensity modulated radiotherapy market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the intensity modulated radiotherapy market. The data is available for historic period 2010-2021.
Competitive Landscape and Global Intensity Modulated Radiotherapy Market Share Analysis
The intensity modulated radiotherapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to intensity modulated radiotherapy market.
Some of the major players operating in the intensity modulated radiotherapy market are:
- Mettler-Toledo (U.S.)
- Varian Medical Systems (U.S.)
- Elekta AB (Sweden)
- Accuray (U.S.)
- Siemens Healthineers (Germany)
- IBA Dosimetry (Belgium)
- Sun Nuclear Corporation (U.S.)
- ViewRay (U.S.)
- RaySearch Laboratories (Sweden)
- Mevion Medical Systems (U.S.)
- Hitachi Healthcare (Japan)
- Prowess Inc. (a subsidiary of Altair) (U.S.)
- Brainlab (Germany)
- Koninklijke Philips N.V. (Netherlands)
SKU-